Estimated US infection- and vaccine-induced Covid seroprevalence based on blood donations

JAMA Network

What The Study Did: Based on a sample of blood donations in the United States from July 2020 through May 2021, vaccine- and infection-induced SARS-CoV-2 seroprevalence increased over time and varied by age, race and ethnicity, and geographic region. Seroprevalence studies estimate how common it is for people to have SARS-CoV-2–specific antibodies due to natural infection or induced by vaccination.

Authors: Jefferson M. Jones, M.D., M.P.H., C.D.R., of the Centers for Disease Control and Prevention in Atlanta, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2021.15161)

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.